Acarbose 50 mg

DRUG2 trials

Sponsors

Novartis Pharmaceuticals, Shifa International Hospital

Conditions

DiabetesDiabetes ComplicationsDiabetes Mellitus, Type 2Diabetic Neuropathy

Phase 1

CGM-Guided Acarbose for Painful Diabetic Neuropathy

CompletedNCT07436585

Shifa International HospitalDiabetes, Diabetes Complications, Diabetic Neuropathy

Start: 2025-09-01End: 2025-12-10Updated: 2026-03-03

Phase 4

Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors

CompletedNCT00928889

Novartis PharmaceuticalsDiabetes Mellitus, Type 2

Start: 2009-07-31End: 2010-06-30Updated: 2012-05-10